Suppr超能文献

泰-萨克斯病:来自澳大利亚的当前观点

Tay-Sachs disease: current perspectives from Australia.

作者信息

Lew Raelia M, Burnett Leslie, Proos Anné L, Delatycki Martin B

机构信息

Department of Obstetrics and Gynecology, QEII Research Institute for Mothers and Infants, The University of Sydney, Australia ; Department of Obstetrics and Gynaecology, Dentistry and Health Sciences, Faculty of Medicine, The University of Melbourne, Melbourne, Australia.

NSW Health Pathology North, Royal North Shore Hospital, St Leonards, Australia ; SEALS, Prince of Wales Hospital, Randwick, Australia ; Sydney Medical School-Northern, Royal North Shore Hospital E25, University of Sydney, Sydney, Australia.

出版信息

Appl Clin Genet. 2015 Jan 21;8:19-25. doi: 10.2147/TACG.S49628. eCollection 2015.

Abstract

Tay-Sachs disease (TSD) is a fatal, recessively inherited neurodegenerative condition of infancy and early childhood. Although rare in most other populations, the carrier frequency is one in 25 in Ashkenazi Jews. Australian high-school-based TSD preconception genetic screening programs aim to screen, educate, and optimize reproductive choice for participants. These programs have demonstrated high uptake, low psychological morbidity, and have been shown to result in fewer than expected Jewish TSD-affected births over 18 years of operation. The majority of Jewish individuals of reproductive age outside of the high school screening program setting in Australia have not accessed screening. Recent recommendations advocate supplementing the community high school screening programs with general practitioner- and obstetrician-led genetic screening of Ashkenazi Jewish individuals for TSD and other severe recessive diseases for which this group is at risk. Massively parallel DNA sequencing is expected to become the testing modality of choice over the coming years.

摘要

泰-萨克斯病(TSD)是一种发生于婴幼儿期和儿童早期的致命性隐性遗传神经退行性疾病。虽然在大多数其他人群中较为罕见,但在阿什肯纳兹犹太人中,携带者频率为二十五分之一。澳大利亚以高中为基础的TSD孕前基因筛查项目旨在为参与者进行筛查、提供教育并优化生育选择。这些项目显示出参与率高、心理发病率低,并且在18年的运行中,受TSD影响的犹太裔婴儿出生数量少于预期。在澳大利亚,大多数处于生育年龄的犹太个体未参与高中筛查项目之外的筛查。最近的建议主张,通过全科医生和产科医生主导的基因筛查,对阿什肯纳兹犹太个体进行TSD及该群体面临风险的其他严重隐性疾病的筛查,以此补充社区高中筛查项目。预计在未来几年,大规模平行DNA测序将成为首选的检测方式。

相似文献

1
Tay-Sachs disease: current perspectives from Australia.
Appl Clin Genet. 2015 Jan 21;8:19-25. doi: 10.2147/TACG.S49628. eCollection 2015.
4
Ashkenazi Jewish population screening for Tay-Sachs disease: the international and Australian experience.
J Paediatr Child Health. 2015 Mar;51(3):271-9. doi: 10.1111/jpc.12632. Epub 2014 Jun 13.
8
Heterozygote screening for Tay-Sachs disease: past successes and future challenges.
Curr Opin Pediatr. 1996 Dec;8(6):625-9. doi: 10.1097/00008480-199612000-00014.
9
Evaluation of a Tay-Sachs disease screening program.
Clin Genet. 2003 May;63(5):386-92. doi: 10.1034/j.1399-0004.2003.00074.x.

引用本文的文献

2
Genetics of catatonia: a systematic review of case reports and a gene pathway analysis.
Eur Psychiatry. 2025 May 22;68(1):e72. doi: 10.1192/j.eurpsy.2025.2458.
3
Differential gene expression patterns in Niemann-Pick Type C and Tay-Sachs diseases: Implications for neurodegenerative mechanisms.
PLoS One. 2025 Mar 19;20(3):e0319401. doi: 10.1371/journal.pone.0319401. eCollection 2025.
4
Diagnosing Late-Onset Tay-Sachs Through Next Generation Sequencing and Functional Enzyme Testing: From Genes to Enzymes.
Neurol Genet. 2024 Oct 23;10(6):e200205. doi: 10.1212/NXG.0000000000200205. eCollection 2024 Dec.
5
Expanded carrier screening for inherited genetic disease using exome and genome sequencing.
J Genet Couns. 2025 Apr;34(2):e1964. doi: 10.1002/jgc4.1964. Epub 2024 Aug 27.
7
Juvenile Tay Sachs Disease Due to Compound Heterozygous Mutation in Hex-A Gene, with Early Sign of Bilateral Tremors.
Ann Indian Acad Neurol. 2022 May-Jun;25(3):502-505. doi: 10.4103/aian.aian_577_21. Epub 2022 Jan 5.
8
Therapeutic Strategies For Tay-Sachs Disease.
Front Pharmacol. 2022 Jul 5;13:906647. doi: 10.3389/fphar.2022.906647. eCollection 2022.
10
Novel HEXA variants in Korean children with Tay-Sachs disease with regression of neurodevelopment from infancy.
Mol Genet Genomic Med. 2021 Jun;9(6):e1677. doi: 10.1002/mgg3.1677. Epub 2021 Apr 3.

本文引用的文献

1
Ashkenazi Jewish population screening for Tay-Sachs disease: the international and Australian experience.
J Paediatr Child Health. 2015 Mar;51(3):271-9. doi: 10.1111/jpc.12632. Epub 2014 Jun 13.
2
Next-generation DNA sequencing of HEXA: a step in the right direction for carrier screening.
Mol Genet Genomic Med. 2013 Nov;1(4):260-8. doi: 10.1002/mgg3.37. Epub 2013 Sep 16.
3
High school Tay-Sachs disease carrier screening: 5 to 11-year follow-up.
J Community Genet. 2014 Apr;5(2):139-46. doi: 10.1007/s12687-013-0163-z. Epub 2013 Jul 27.
4
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
Genet Med. 2013 Jul;15(7):565-74. doi: 10.1038/gim.2013.73. Epub 2013 Jun 20.
5
Current practice and attitudes of Australian obstetricians toward population-based carrier screening for inherited conditions.
Twin Res Hum Genet. 2013 Apr;16(2):601-7. doi: 10.1017/thg.2012.152. Epub 2013 Jan 21.
7
Recent advances in the prenatal interrogation of the human fetal genome.
Trends Genet. 2013 Feb;29(2):84-91. doi: 10.1016/j.tig.2012.10.013. Epub 2012 Nov 15.
10
Carrier testing for severe childhood recessive diseases by next-generation sequencing.
Sci Transl Med. 2011 Jan 12;3(65):65ra4. doi: 10.1126/scitranslmed.3001756.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验